1
2
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T9924 | Obinutuzumab | Obinutuzumab/afutuzumab | Others |
Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma. |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPK-00184 | CD20 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | E. coli |
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until matur... | |||
TMPK-00183 | CD20 Protein, Human, Recombinant (His & Avi) | Human | E. coli |
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until matur... |